FDCs for Hypertension & CVD
Cardiovascular Disease
ANDA Filed/DevelopmentActive
Key Facts
About RPG Life Sciences
RPG Life Sciences operates as a formulation and manufacturing-driven pharmaceutical company, aiming to provide high-quality, affordable medicines across key therapeutic segments in India. Its core achievements include building a robust, diversified product portfolio, establishing extensive distribution reach, and maintaining regulatory-compliant manufacturing capabilities. The company's strategy leverages its position within the RPG group to capitalize on India's demographic and healthcare infrastructure tailwinds, focusing on portfolio expansion and operational efficiency to drive growth.
View full company profileTherapeutic Areas
Other Cardiovascular Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| Manocept Diagnostic | Navidea Biopharmaceuticals | Research |
| Undisclosed Therapeutic Program(s) | HeartcoR Solutions | Pre-clinical |
| Ramatroban (KAR101) | KARE Biosciences | Preclinical |
| Undisclosed Cardiovascular Device Program | Transluminal Technologies | Pre-clinical |
| iPSC-CM Cell Therapy | Khloris Biosciences | Research |
| Clinical Trial Integration | Aktiia | Various |
| Cardiovascular Disease Study | Arizona Research Center | Not Specified |
| Cardiovascular Clinical Trials | PanThera Bio | Not Specified |
| Undisclosed | Zecardio Therapeutics | Discovery/Pre-clinical |
| HDL/LDL Regulation | Alpha-1 Biologics | Pre-clinical |
| Cardiovascular Program | Helixomer | Research |
| Undisclosed Cardiovascular Program | inQB8 Medical Technologies | Pre-clinical |